BioVanguard Therapeutics
Verified OrganizationEnterpriseBiotech & Life SciencesTargeted mRNA Delivery Platforms for Rare Autoimmune Disorders
π About BioVanguard Therapeutics
BioVanguard Therapeutics is a clinical-stage biotechnology company developing tissue-targeted lipid nanoparticle (LNP) vectors. We partner with academic research hospitals to accelerate curative gene-regulating therapeutics for rare and underserved patient populations.
πΌ Careers & Volunteer Opportunities (0)
Organization Details
- Legal Type
- for profit
- Tax ID / EIN
- 04-9102938
- Headquarters
- Cambridge, Massachusetts, USA
- Platform Status
- β Verified Active
- Founded
- 2021
- Company Size
- 11-50 employees Employees
π Direct Contact
PublicπΊοΈ Location & Directions
Google MapsOne Kendall Square, Building 600, Cambridge, MA, United States
Get Directions on Google Maps →π Verified Social Links
Do you own or manage a company? Boost your Google & AI search rankings with a free verified profile.
